MedPath

Retrospective study to understand the patient profile and prescribing pattern for amlodipine and its combinations in patients with primary hypertension.

Not Applicable
Conditions
Health Condition 1: I10- Essential (primary) hypertension
Registration Number
CTRI/2023/09/057949
Lead Sponsor
Dr Reddys Laboratories Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

EMR records of patients =18 years of age

• EMR records of patients with clinically diagnosed as primary hypertensive ?

• EMR records of patients prescribed with amlodipine or its combinations with or without other antihypertensive agents in any visit other than the first visit on EMR platform.

• EMR records of patients with a follow up within 10-30 days from prescription of amlodipine/its combinations.

Exclusion Criteria

Patients with hypertension due to secondary reasons – viz. pregnancy induced hypertension.

• Patients with incomplete data on EMR platform.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To study the prescription pattern of amlodipine and its <br/ ><br>combinations in patients with different patient profiles and clinical features and comorbidities like diabetes mellitus, chronic kidney disease, coronary artery disease and other cardiac diseases and stroke at baseline in EMR records.Timepoint: Outcome analysis will be done for the patients who have a follow up visit within 10-30 days from prescription of amlodipine or its combinations
Secondary Outcome Measures
NameTimeMethod
To assess the change in SBP and DBP from baseline (index date) to follow-up in all the <br/ ><br>patients (with/without any comorbid condition). <br/ ><br>• To assess the incidence of pedal edema. <br/ ><br>• To evaluate percentage of patients who achieved target blood pressure at follow up.Timepoint: Data will be captured for one consecutive follow-up <br/ ><br>visit within 10-30 days from the baseline visit/index date
© Copyright 2025. All Rights Reserved by MedPath